Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,371 | 4,930 | 1,421 | 949 | 1,103 |
| Receivables | N/A | 10 | 10 | 58 | 63 |
| TOTAL | $2,622 | $5,056 | $1,573 | $1,259 | $1,461 |
| Non-Current Assets | |||||
| PPE Net | 33 | 47 | 61 | 75 | 94 |
| Other Non-Current Assets | 1,069 | 1,164 | 1,256 | 1,345 | 1,432 |
| TOTAL | $1,102 | $1,211 | $1,317 | $1,420 | $1,526 |
| Total Assets | $3,724 | $6,267 | $2,890 | $2,679 | $2,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 385 | 569 | 1,447 | 1,030 | 890 |
| Accrued Expenses | 1,551 | 1,900 | 2,266 | 2,696 | 2,385 |
| TOTAL | $2,321 | $2,840 | $4,071 | $4,071 | $3,608 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 566 | 674 | 780 | 883 | 982 |
| TOTAL | $566 | $674 | $780 | $883 | $982 |
| Total Liabilities | $2,887 | $3,514 | $4,851 | $4,954 | $4,590 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,680 | 4,584 | 2,124 | 1,821 | 1,783 |
| Common Shares | 5 | 5 | 2 | 27 | 2 |
| Retained earnings | -160,121 | -157,825 | -156,088 | -154,442 | -152,175 |
| TOTAL | $837 | $2,753 | $-1,961 | $-2,275 | $-1,603 |
| Total Liabilities And Equity | $3,724 | $6,267 | $2,890 | $2,679 | $2,987 |